The repurposed anthelmintic
mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma.
Oral administration of
mebendazole in mice elicited a strong antitumor effect in a subcutaneous model and reduced lesions in experimentally induced lung metastasis without any toxicity when compared with paclitaxel - treated mice [9,20].
Nygren P, Larsson R. Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug
mebendazole in refractory metastatic colon cancer.
Not exact matches
In a previous paper published in ecancermedicalscience, the ReDO researchers examined the anti-cancer properties of the drug mebendazole, an over-the-counter treatment currently used for threadwor
In a previous paper published
in ecancermedicalscience, the ReDO researchers examined the anti-cancer properties of the drug mebendazole, an over-the-counter treatment currently used for threadwor
in ecancermedicalscience, the ReDO researchers examined the anti-cancer properties of the drug
mebendazole, an over-the-counter treatment currently used for threadworm.
Janssen GPH will also prioritise work with the International Partnership for Microbicides developing the investigational drug dapivirine for use as a monthly vaginal microbicidal ring designed to prevent sexual transmission of HIV and continue its pact with Drugs for Neglected Diseases initiative for the preclinical research of a reformulated form of flubendazole for lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), Janssen GPH is also developing a new, chewable formulation of Vermox (
mebendazole) that will facilitate treatment of intestinal worms
in younger children.
XIAP downregulation accompanies
mebendazole growth inhibition
in melanoma xenografts.
Correspondingly, the
in vivo growth of hedgehog - dependent medulloblastoma was inhibited by orally administered
mebendazole.
Dosing of
mebendazole of 30 - 87 mg / kg / day
in humans resulted
in plasma levels of 120 -218 nM (260 nM for continuous administration) with coefficients of variation ranging from 27 to 72 %.
In human cells,
mebendazole suppressed the formation of the primary cilium, a microtubule - based organelle that functions as a signaling hub for Hh pathway activation.
The benzamidazole
mebendazole significantly inhibited growth of adrenocortical carcinoma cells, both
in vitro and
in vivo, the effects being due to induction of apoptosis [19].
The anthelmintic drug
mebendazole inhibits growth, migration and invasion
in gastric cancer cell model.
Anticancer activities of anthelminthics were reported for
mebendazole by Mukhopadhyay et al.
in 2002, for pyrvinium pamoate (PPAM) by Esumi et al.
in 2004 and for niclosamide by Wang et al.
in 2009, respectively [8 - 10].
Examples of drugs identified as high - potential agents within the Repurposing Drugs
in Oncology (ReDO) project include
mebendazole, cimetidine, nitroglycerin, diclofenac and clarithromycin, among others [3].
Moreover,
mebendazole inhibited invasion and migration of cancer cells
in vitro, and formation of metastases
in vivo
in experimental animals.
The existing therapies that will be combined
in the METRICS study are metformin, statins, doxycycline,
mebendazole and ibuprofen, but it was by no means a straightforward process to land on these particular medicines.
In the conventional world of medicine, one of the mainstays is
mebendazole.